Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM movers: WH Ireland could lose general meeting vote and Angle refines strategy

AIM movers: Reabold Resources selling LNEnergy stake and First Development Resources drilling difficulties

AIM movers: HSS hire transformation and Quartix upgrade

AIM weekly movers: Hydrogen storage prospects improve for UK Oil and Gas

Aquis weekly movers: Richmond Hill returns from suspension after prospectus launched

AIM movers: Polar Capital upgraded

AIM movers: Boku is AIM company of the year and ex-dividends

AIM movers: UK Oil and Gas collaboration with National Gas Transmission and Litigation Capital Management loss

AIM movers: SEEEN grows revenues and Billington hit by delays

AIM movers: EnergyPathways confirms MESH recommendation and Spectra Systems downgrade

Directors deals: Finseta buying after poor interims

AIM movers: EnergyPathways’ MESH nears approval

Aquis weekly movers: All Things Considered increases revenues

AIM movers: Brighter outlook for Gemfields and EnergyPathways share price recovers

AIM movers: Arecor Therapeutics collaboration and ex-dividends

AIM movers: Nigel Wray doubles stake in Sosandar and Fiske under FCA restrictions

AIM movers: Keystone Law upgraded and weaker spending at System1

AIM movers: WH Ireland selling wealth management business and Nuvec success for N4 Pharma

Director deals: Wynnstay Properties discount buy

AIM weekly movers: Futura Medical considering options

Aquis weekly movers: Equipmake gets £5.45m order

AIM movers: Sales remain weak for Futura Medical and Gelion awarded grant

AIM movers: Helium confirmed at Sagebrush for Mosman Oil and ex-dividends

AIM movers: Nexteq Brazilian order and Autins hit be production halt at JLR

AIM moves: Focusrite improves revenues and Manolete Partners expects significant second half weighting

AIM movers: Renalytix collaboration and Litigation Capital Management terminates involvement in case

Director deals: Altitude buying after share price decline

Aim weekly movers: Angle directors leave

Aquis weekly movers: Shortwave Life Sciences plans clinical study

AIM movers: Angle executives step down and Atome secures offtake agreement

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020